Adaptin Bio (APTN) Current Assets (2022 - 2026)

Adaptin Bio (APTN) has 5 years of Current Assets data on file, last reported at $706117.0 in Q1 2026.

• For the quarter ending Q1 2026, Current Assets fell 75.26% year-over-year to $706117.0; the trailing twelve-month figure through Mar 2026 stood at $706117.0 (down 75.26% YoY), and the FY2025 full-year result was $619159.0, up 1259.62% from the prior year.
• Current Assets improved to $706117.0 in Q1 2026, from $619159.0 in the prior quarter.
• In the past five years, Current Assets ranged from a high of $2.9 million in Q1 2025 to a low of $322.0 in Q2 2024.
• A 5-year average of $572434.3 and a median of $23019.5 in 2022 frame the typical range for Current Assets.
• Across the five-year window, Current Assets surged 750953.68% in 2025 and plunged 75.26% in 2026, its largest moves.
• Tracing APTN's Current Assets over 5 years: stood at $500.0 in 2022, then retreated by 24.0% to $380.0 in 2023, then soared by 11883.95% to $45539.0 in 2024, then soared by 1259.62% to $619159.0 in 2025, then advanced by 14.04% to $706117.0 in 2026.
• Business Quant data shows APTN's Current Assets at $706117.0 in Q1 2026, $619159.0 in Q4 2025, and $979474.0 in Q3 2025.